Dr. Joseph Kozikowski will present on the use of transdermal sustained delivery oxygen therapy for diabetic foot ulcers at the nation’s leading direct-to-patient medical supply company.
FRAMINGHAM, MA – March 1, 2004 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will present to executive and clinical leadership at Edgepark Medical Headquarters.
As an authority on the development and commercialization of advanced medical technology, Dr. Kozikowski will share his perspectives in a presentation entitled “Transdermal Oxygen Delivery Oxygen for Improving Outcomes of Diabetic Foot Ulcers and Venous Stasis Ulcers” on March 12, 2004 in Twinsburg, OH.
The presentation will address Dr. Kozikowski’s translational research in transdermal sustained delivery oxygen therapy as Medical Director of Ogenix, Inc. (Cleveland, OH).
About Edgepark:
Edgepark Medical Supplies contracts directly with more than 600 managed care organizations to provide direct-to-patient home delivery of products to patients.
